Close
Patheon

Recorded Webcasts

Sep
12
2017

Ensure the Scalability of Your Molecule with a Science-Driven, Phase-Appropriate Approach

The pharmaceutical development of a product can be a difficult journey to navigate with lots of ups and downs along the way. Many challenges can arise that pose a risk to timelines, cost, and clinical success. ...View More

Sep
19
2016

What to Look For in a Solubility Enhancement Vendor

Author: Kaspar Van den Dries, Senior Director Formulation Sciences
Patheon's Kaspar Van den Dries explains which crucial characteristics you should look for when selecting a solubility enhancement vendor. ...View More

Sep
12
2016

Amorphous Dispersion Drug Formulations: A Modern Simulation-Based Approach

Author: Matthew D. Wessel, PhD and Tom Reynolds, PhD
Nearly 75% of drugs in development have solubility challenges which often leads to failure in clinical trials. Fortunately, by addressing solubility earlier in a development program, timelines can be shortened and risks can be mitigated. ...View More

Jul
12
2016

The Advantages of a Employing a Lipid-Based Formulation Process in Early Development

Author: Kaspar van den Dries, Ph.D.
In this webinar, experts will explain the benefits of considering lipid formulation early in the development process and how a structured screening and development approach can assist in overcoming potential barriers associated with lipid formulations. Speakers: Martin Piest, PhD, Senior Formulation Scientist and Kaspar van den Dries, PhD, Senior Director and Principle Scientist, Solid Dose Development at Patheon. ...View More

Apr
21
2016

Taking An Informed Approach To Technology Selection To Address Solubility Challenges In Early Development

Author: Jon Sutch, Ph.D, Senor Manager of Formulation Development, Patheon & Christopher M. Lindemann, President, Focus Pharmaceutics, LLC
As the need for more targeted drug therapies has increased and drug development has become more complex, the industry has seen a corresponding rise in the number of molecules with low solubility challenges. In fact, up to 90% of today’s drug candidates are plagued with low solubility. In light of this challenge, drug formulators must look to new techniques and formulation technologies to proactively address low solubility challenges and ensure effective treatments are reaching patients in need. ...View More

Mar
13
2016

Taking a More Informed Approach to Solubility Enhancement

Author: Marshall Crew, Ph.D., VP. PDS Global Science
Marshall Crew, Ph.D, partners with Pharmaceutical Technology magazine to discuss optimal development programs for molecules of various solubility level, and how it affects future planning. ...View More

Sep
12
2017

Choosing the Best Biomanufacturing Strategy: The Value of a Multi-Pronged Approach

Author: Barry Rosenblatt, PhD, President, SME Biotech Consulting Dave Kenyon, PhD, Vice President, Process Sciences, Patheon
Biopharma executives face a daunting number of decisions daily as they address the challenges of bringing drugs—which may be unstable and unpredictable—to market. Perhaps the most important decision is selecting the biomanufacturing strategy that is the best fit for their organization. ...View More

Dec
27
2016

Top 5 Considerations When Looking to Outsource to a Biomanufacturing Partner

Author: Paul Jorjorian
Join Paul Jorjorian for a 20 minute “Ask the Expert” webcast with BioProcess International, as he reviews how biopharmaceutical companies are facing increasing constraints when developing and manufacturing their large molecule drugs and how, as a result, selection of the right biomanufacturing partner is critical. ...View More

Jun
16
2016

Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing

Author: Stephan Lam, Senior VP Biologics, Patheon & Patti Seymour, Senior Consultant, BPTC & Susan Sebelsky, Research Director, ORC
Large molecule drug substance manufacturing and demand forecasting is riddled with complexity. The long cycle time and short shelf life of biologic drug substance makes it difficult to adapt the supply chain with agility, even at the earliest stages of development. As a result, inaccurate demand forecasts can have significant implications for companies developing biologics. And with less industry-wide available capacity for biologic production, it is increasingly difficult to locate capacity to respond to demand changes and ensure products achieve commercial goals. ...View More

Jun
28
2017

Anticipating the Formulation Challenges of Complex Molecules

Author: Michael P. Cruskie Jr., PhD, Executive Director and General Manager, API Florence, SC, Patheon, Anil Kane, PhD, MBA, Executive Director, Global Head of Technical and Scientific Affairs, Patheon, & Stephen Closs, Vice President, Global Technical Operations (GTO), Global Engineering and Applied Technology, Patheon
Formulation problems are arising with greater frequency, delaying development, and burdening developers with unanticipated and heavy costs. Identifying the critical attributes of the API and having a full understanding of the impact of these on the drug product manufacturing and scale up is the key to anticipate problems and address them early. Adapting the API manufacturing process and an early systematic characterization could prepare the drug developers to solve problems earlier in the program. ...View More

Jun
15
2017

Trends and Challenges in Outsourced Oral Solid Dosage Forms

Author: Anil Kane, Ph.D., MBA, Executive Director, Global Head of Technical and Scientific Affairs, Patheon
As drug companies have fewer and fewer new compounds entering their R&D pipelines, outsourcing of development and manufacturing activities for oral solid dosage forms and sterile forms is on the rise. Pharmaceutical Technology recently spoke with Anil Kane, PhD, MBA, executive director and global head of technical and scientific affairs at Patheon, about trends and significant changes in outsourcing the manufacture and development of solid oral dosage forms. ...View More

Jul
7
2016

Early Stage Development for Solid Dose Products

Author: Kaspar Van den Dries, Senior Director Formulation Sciences & Michiel Heslinga, Program Manager, Global Integration
In this webcast recording, we review the challenges which are experienced in early stage development of solid oral dosage forms. We look at the implications of these challenges on a development program and discuss hurdles such as bioavailability challenges of poorly soluble molecules early on in development, development of paediatric dosage forms, and the complexity of the CMC work stream. ...View More

Sep
12
2017

Curbing the Opioid Epidemic with Pacira Pharmaceuticals

Author: Rich Whitworth, Content Director, The Medicine Maker Steve McCairns, Executive Director of UK Operations, Pacira Pharmaceuticals
Pacira Pharmaceuticals is working to curb the opioid epidemic with its injectable suspension, EXPAREL®. EXPAREL is produced at Patheon’s Swindon facility, creating a strategic partnership between the two companies. ...View More

Jun
15
2017

How Adaptable Manufacturing Models are Paving a Steady Path Into an Unpredictable Future

Author: Joe Principe, Vice President of Strategic Partnerships, Patheon, Rich Whitworth, Content Director, The Medicine Maker, & Steve McCairns, Executive Director of UK Operations, Pacira
View Patheon’s short video webinar, "How adaptable manufacturing models are paving a steady path into an unpredictable future," hosted by Rich Whitworth from The Medicine Maker. In this webinar, Rich sits down to discuss real-world implementations of adaptable manufacturing models with Patheon's Joe Principe, Vice President of Strategic Partnerships, and Pacira’s Steve McCairns, Executive Director of UK Operations. ...View More

Jul
10
2016

Executive Research: Impact of Incorrect Forecasts on New Product Launches

Author: Susan Sebelsky, Director, ORC International, Jim Miller, MBA President, PharmSource, & Joe Principe Vice President, Strategic Partnerships, Patheon
ORC International recently completed extensive interviews with 50 pharma executives, who consistently utilize launch forecasts to predict manufacturing planning and volume. Join this webinar as we discuss the results of this study, including forecasting processes, key issues that arise from inaccurate forecasts, and how forecasting needs will change over the next few years due to evolving organizational needs. ...View More

Looking for Solutions?

We can help.